Home > > Global Automated and Closed Cell Therapy Processing Systems Market Report
The Automated and Closed Cell Therapy Processing Systems market was valued at $646.1 Million in 2022, and is projected to reach $1,134.2 Million by 2032 growing at a CAGR of 5.85% from 2023 to 2032.Automated and closed cell therapy processing systems are a type of medical device that are used to process cells for use in cell therapies, which are a type of medical treatment that involves the use of living cells to treat or cure a disease or condition. These systems are designed to automate and streamline the cell therapy manufacturing process, and are used in a variety of applications including the production of cell-based therapies for cancer, autoimmune disorders, and regenerative medicine. There are several drivers that are expected to contribute to the growth of the automated and closed cell therapy processing systems market in the coming years. These include: Increasing demand for cell-based therapies: As the use of cell-based therapies for the treatment of various diseases and conditions becomes more widespread, the demand for automated and closed cell therapy processing systems is expected to increase. Advances in cell processing technology: Improvements in cell processing technology, such as the development of closed systems and automated processes, are expected to drive market growth. Government support and funding: Governments around the world are investing in the development of cell therapies and are providing funding for research and development, which is expected to drive the growth of the automated and closed cell therapy processing systems market. Growing focus on quality and safety: As cell therapies become more prevalent, there is an increased focus on ensuring the quality and safety of these therapies. Automated and closed cell therapy processing systems can help to ensure the quality and safety of cell therapies by automating and standardizing the manufacturing process. Some of the top companies in the automated and closed cell therapy processing systems market include: GE Healthcare Thermo Fisher Scientific Merck KGaA Sartorius AG Danaher Corporation These companies have a strong presence in the market and have made significant developments in the field of automated and closed cell therapy processing systems. For example, GE Healthcare has developed a range of cell processing systems including the KUBio biomanufacturing platform, which is a fully automated, closed system for the production of cell therapies.